A key part of the project will be a randomised, controlled trial across European countries led by ESCAPE project partner Professor Christoph Herrmann-Lingen, Universitätsmedizin Göttingen (Germany).

Focusing on patients with chronic heart failure, psychological distress and at least two other physical co-morbidities, the trial will compare the outcomes of ESCAPE’s new, blended collaborative care approach with current patient care. Researchers will determine which approach leads to the best health-related quality of life for patients.